We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$7.14B
Cap. Flow %
-8.9%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734

Sector Composition

Rank Sector Weight
1 Technology 12.69%
2 Industrials 9.96%
3 Consumer Discretionary 8.03%
4 Healthcare 7.46%
5 Financials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEP icon
3176
Korea Electric Power
KEP
$14.5B
-15,786
Closed -$225K
KIDS icon
3177
OrthoPediatrics
KIDS
$670M
-15,006
Closed -$238K
KIO
3178
KKR Income Opportunities Fund
KIO
$449M
-76,042
Closed -$836K
KMB icon
3179
PUT
Kimberly-Clark
KMB
$36.4B
-101,600
Closed -$9.8M
KMPR icon
3180
Kemper
KMPR
$1.59B
-459,765
Closed -$14.1M
KNTK icon
3181
Kinetik
KNTK
$4.38B
-912,865
Closed -$44.2M
KOP icon
3182
Koppers
KOP
$855M
-14,356
Closed -$555K
KPTI icon
3183
CALL
Karyopharm Therapeutics
KPTI
$44.5M
-100,000
Closed -$557K
KPTI icon
3184
Karyopharm Therapeutics
KPTI
$44.5M
-70,748
Closed -$394K
KRNT icon
3185
Kornit Digital
KRNT
$721M
-30,621
Closed -$449K
KRP icon
3186
Kimbell Royalty Partners
KRP
$1.55B
-18,335
Closed -$265K
KRUS icon
3187
Kura Sushi USA
KRUS
$587M
-281,285
Closed -$19.6M
KSA icon
3188
iShares MSCI Saudi Arabia ETF
KSA
$632M
-40,000
Closed -$1.59M
KT icon
3189
KT
KT
$9B
-78,199
Closed -$1.68M
KVUE icon
3190
CALL
Kenvue
KVUE
$36.6B
-800,000
Closed -$13.8M
KW
3191
DELISTED
Kennedy-Wilson Holdings
KW
-773,784
Closed -$8.37M
KZIA
3192
Kazia Therapeutics
KZIA
$153M
-193,114
Closed -$1.44M
MZTI
3193
The Marzetti Company
MZTI
$3.06B
-82,294
Closed -$11.4M
LBRDA
3194
DELISTED
Liberty Broadband Class A
LBRDA
-7,642
Closed -$384K
LE icon
3195
Lands' End
LE
$375M
-290,903
Closed -$3.27M
LFST icon
3196
Lifestance Health
LFST
$4.76B
-391,149
Closed -$2.49M
LILA icon
3197
Liberty Latin America Class A
LILA
$1.66B
-158,128
Closed -$928K
LIN icon
3198
CALL
Linde
LIN
$225B
-18,000
Closed -$8.92M
LINC icon
3199
Lincoln Educational Services
LINC
$816M
-21,134
Closed -$860K
LIVN icon
3200
LivaNova
LIVN
$4.34B
-167,300
Closed -$10.6M

Similar funds

Dmitry Balyasny's Q2 2026 Portfolio in Review

As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.

  • Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
  • Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.